Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models
Highlights •In a retrospective study, ex vivo drug testing predicts GBM patient survival •Testing is based on detecting subtle changes in single-cell mass •Predictive power of functional testing